1997 FDA Approved Drugs

The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. Review descriptions for our medical therapeutic area list to help assist in your search.

Join our Drug Research Updates group on LinkedIn! 
Find out more about the types of drugs included in this listing.

Cardiology/Vascular Diseases

Baycol (cerivastatin sodium); Bayer; Treatment for high cholesterol, Approved June 1997; withdrawn 8/8/01

Captopril and hydrochlorotiazide; Mylan Laboratories; Treatment for hypertension, Approved May 1997

Cardizem (R) (Diltiazem HC1 for injection) Monvial (R); Hoechst Marion Roussel; Delivery system for Monovial, Approved September 1997

Corlopam; Neurex; Treatment for severe high blood pressure, Approved September 1997

Diovan (valsartan); Ciba Pharmaceuticals; Treatment for hypertension, Approved January 1997

DynaCirc CR; Novartis; Treatment for hypertension, Approved February 1997

EDEX; Schwarz Pharma; Treatment for erectile dysfunction, Approved June 1997

Lescol (fluvastatin sodium); Novartis; Treatment for coronary atherosclerosis, Approved September 1997

Lexxel (enalapril maleate-felodipine ER); Astra Merck; Treatment for hypertension, Approved January 1997

Microzide (hydrochlorothiazide); Watson Pharmaceuticals; Treatment for mild-to moderate hypertension, Approved January 1997

Normiflo; Wyeth; Treatment for deep venous thrombosis, Approved May 1997

Pentoxifylline; Faulding, Mylan Laboratories; Generic equivalent of Trental, Approved July 1997

Pindolol; Teva Pharmaceutical; Generic equivalent of Visken, Approved April 1997

Plavix (clopidogrel bisulfate); Sanofi-aventis, Bristol-Myers Squibb; Treatment for cardiac atherosclerotic events, Approved November 1997

Posicor; Roche; Treatment for hypertension and chronic stable angina pectoris, Approved June 1997

ReoPro; Centocor Ortho Biotech; Treatment for cardiac ischemic complications, Approved November 1997

REPRONEX(menotropins for injection, USP); Ferring Pharmaceuticals; Generic equivalent of Pergonal, Approved February 1997

Teveten (eprosartan mesylate); SmithKline Beecham; Treatment for hypertension, Approved December 1997

Verapamil; IVAX; Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR, Approved December 1997

Warfarin Sodium tablets; Barr Laboratories; Generic equivalent of Coumadin, Approved March 1997

Zocor; Merck; Treatment for high cholesterol, Approved November 1997

Dental and Oral Health

Aphthasol; Block Drug Company; Treatment for canker sores, Approved December 1997

Dermatology

Avita Gel; Penederm; Treatment for acne, Approved January 1997

Bactroban Cream; SmithKline Beecham; Treatment for secondarily infected traumatic skin lesions, Approved December 1997

Clindamycin Phosphate Topical Solution USP 1%; Morton Grove Pharmaceuticals; Generic equivalent of CLEOCIN Topical Solution 1%, Approved July 1997

Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Dermagraft-TC; Advanced Tissue Sciences; Treatment for partial-thickness and severe burns, Approved October 1997

Klaron (sodium sulfacet amide lotion ) Lotion, 10%; Dermik Laboratories; Treatment for adult acne, Approved February 1997

Mentax (1% butenafine HCl cream); Penederm; Treatment for tinea corporis (ringworm) and tinea cruris (groin fungus), Approved January 1997

Mentax (1% butenafine HCl cream); Penederm; Treatment for athlete's foot, Approved December 1997

Minoxidil Topical Solution 2% for Women; Alpharma; Generic equivalent of Rogaine, Approved April 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Ortho-McNeil Pharmaceutical; Treatment for acne in women seeking contraception, Approved January 1997

Propecia; Merck; Treatment for male baldness, Approved December 1997

REGRANEX (becaplermin) Gel; RW Johnson; Treatment for diabetic foot ulcers, Approved December 1997

Retin-A Micro (tretinoin gel) microsphere, 0.1%; Advanced Polymer Systems; Treatment for acne, Approved February 1997

Tazorac topical gel; Allergan; Treatment for Psoriasis, Acne Vulgaris, Approved June 1997

Endocrinology

Baycol (cerivastatin sodium); Bayer; Treatment for high cholesterol, Approved June 1997; withdrawn 8/8/01

Captopril and hydrochlorotiazide; Mylan Laboratories; Treatment for hypertension, Approved May 1997

Corlopam; Neurex; Treatment for severe high blood pressure, Approved September 1997

Crinone 8% (progesterone gel); Wyeth; Treatment for infertile women with pregestone deficiency, Approved May 1997

Diovan (valsartan); Ciba Pharmaceuticals; Treatment for hypertension, Approved January 1997

Dostinex Tablets (cabergoline tablets); Pharmacia & Upjohn; Treatment of hyperprolactinemic disorders, Approved January 1997

DynaCirc CR; Novartis; Treatment for hypertension, Approved February 1997

Effexor XR (venlafaxin HCI); Wyeth; Treatment of depression, Approved October 1997

Estradiol tablets; Barr Laboratories; Generic equivalent of Estrace, Approved October 1997

Estradiol tablets; Duramed Pharmaceuticals; Generic equivalent of Estrace tablets, Approved December 1997

Estrostep (norethindrone acetate and ethinyl estradiol); Warner-Lambert; Treatment for oral contraception, Approved March 1997

Etodolac; Royce Laboratories; Generic equivalent of Lodine, Approved April 1997

Evista (raloxifene hydrochloride); Eli Lilly; Treatment for the prevention of osteoporosis, Approved December 1997

Femara (letrozole); Novartis; Treatment for breast cancer, Approved July 1997

Follistim (TM) (follitropin beta for injection); Organon; Treatment for infertility, Approved September 1997

Genotropin (somatropin) lyophilized powder; Pharmacia & Upjohn; Treatment for growth hormone deficiency in adults, Approved November 1997

Geref (sermorelin acetate for injection); Serono Laboratories; Treatment for pedicatric growth disorder, Approved October 1997

Gliadel Wafer (polifeprosan 20 with carmustine implant); Rhone-Poulenc Rorer, Guilford Pharmaceuticals; Treatment for brain cancer, Approved February 1997

Glipizide Tablets; Duramed Pharmaceuticals; Treatment for diabetes, Approved September 1997

Glyburide Tablets; Roche; Treatment for blood-glucose lowering, Approved December 1997

Glyburide Tablets; Mova Pharmaceutical; Generic version of Glynase PresTab, Approved December 1997

Gonal-F (follitropin alfa for injection); Serono Laboratories; Treatment for infertility, Approved September 1997

Lescol (fluvastatin sodium); Novartis; Treatment for coronary atherosclerosis, Approved September 1997

Lexxel (enalapril maleate-felodipine ER); Astra Merck; Treatment for hypertension, Approved January 1997

MERIDIA; Knoll Pharmaceutical; Treatment for obesity, Approved November 1997

Microzide (hydrochlorothiazide); Watson Pharmaceuticals; Treatment for mild-to moderate hypertension, Approved January 1997

Norditropin (somatropin (rDNA origin) for injection); Novo Nordisk; Treatment of children who have growth failure, Approved February 1997

Nutropin (somatropin-rDNA origin); Genentech; Treatment for growth hormone deficiency, Approved December 1997

Pindolol; Teva Pharmaceutical; Generic equivalent of Visken, Approved April 1997

Plavix (clopidogrel bisulfate); Sanofi-aventis, Bristol-Myers Squibb; Treatment for cardiac atherosclerotic events, Approved November 1997

Posicor; Roche; Treatment for hypertension and chronic stable angina pectoris, Approved June 1997

Prandin; Novo Nordisk; Treatment for Type II diabetes, Approved December 1997

Prograf; Fujisawa Healthcare; Treatment for the prevention of kidney transplant rejection, Approved April 1997

REGRANEX (becaplermin) Gel; RW Johnson; Treatment for diabetic foot ulcers, Approved December 1997

REPRONEX(menotropins for injection, USP); Ferring Pharmaceuticals; Generic equivalent of Pergonal, Approved February 1997

Skelid (tiludronate disodium); Sanofi-aventis; Treatment for Paget’s disease of bone, Approved March 1997

Testoderm TTS CIII; Alza; Treatment for testosterone deficiency, Approved December 1997

Teveten (eprosartan mesylate); SmithKline Beecham; Treatment for hypertension, Approved December 1997

Trazadone 150mg; Teva Pharmaceutical; Generic equivalent of Desyrel 7, Approved May 1997

Trivora-21 and Trivora-28; Watson Pharmaceuticals; Generic equivalents of levonorgestrel and ethinyl estradiol, Approved December 1997

Verapamil; IVAX; Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR, Approved December 1997

Zenapax; Roche; Treatment to prevent rejection of kidney transplants, Approved December 1997

Zerit (stavudine); Bristol-Myers Squibb; Treatment for infants and children infected with HIV, Approved January 1997

Family Medicine

INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed); SmithKline Beecham; Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children, January 1997

Aphthasol; Block Drug Company; Treatment for canker sores, Approved December 1997

Arthrotec; Searle; Treatment for arthritis, Approved December 1997

Asacol (mesalamine); Procter & Gamble; Treatment of ulcerative colitis, Approved August 1997

Avita Gel; Penederm; Treatment for acne, Approved January 1997

Bactroban Cream; SmithKline Beecham; Treatment for secondarily infected traumatic skin lesions, Approved December 1997

Bromfenac; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997

Captopril and hydrochlorotiazide; Mylan Laboratories; Treatment for hypertension, Approved May 1997

Carbatrol; Elan Pharmaceuticals; Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997

Ceftin (cefuroxime axetil); GlaxoSmithKline; Treatment of secondary bacterial infections of acute bronchitis, Approved September 1997

Cimetadine Hydrochloride Oral Solution 300mg/5ml; Morton Grove Pharmaceuticals; Generic equivalent of Tagamet Oral Solution, Approved October 1997

Cimetidine Hydrochloride Oral Solution; Hi-Tech Pharmacal; Generic equivalent of Tagamet Oral Solution, 300 mg/5 ml, Approved October 1997

Cipro (ciprofloxacin HCl); Bayer; Treatment for acute sinusitis, Approved June 1997

Clindamycin Phosphate Topical Solution USP 1%; Morton Grove Pharmaceuticals; Generic equivalent of CLEOCIN Topical Solution 1%, Approved July 1997

Combivir; GlaxoSmithKline; Treatment for AIDS and HIV Infection, Approved September 1997

Copaxone; Teva Pharmaceutical; Treatment for relapsing-remitting multiple sclerosis, Approved January 1997

Corlopam; Neurex; Treatment for severe high blood pressure, Approved September 1997

Dermagraft-TC; Advanced Tissue Sciences; Treatment for partial-thickness and severe burns, Approved October 1997

Diovan (valsartan); Ciba Pharmaceuticals; Treatment for hypertension, Approved January 1997

DynaCirc CR; Novartis; Treatment for hypertension, Approved February 1997

EDEX; Schwarz Pharma; Treatment for erectile dysfunction, Approved June 1997

Effexor XR (venlafaxin HCI); Wyeth; Treatment of depression, Approved October 1997

Estradiol tablets; Barr Laboratories; Generic equivalent of Estrace, Approved October 1997

Estradiol tablets; Duramed Pharmaceuticals; Generic equivalent of Estrace tablets, Approved December 1997

Etodolac; Royce Laboratories; Generic equivalent of Lodine, Approved December 1997

Etodolac; Royce Laboratories; Generic equivalent of Lodine, Approved April 1997

Evista (raloxifene hydrochloride); Eli Lilly; Treatment for the prevention of osteoporosis, Approved December 1997

Femara (letrozole); Novartis; Treatment for breast cancer, Approved July 1997

FEMSTAT One; Roche; Treatment for vaginal yeast infections, Approved Februrary 1997

FLOMAX; Boehringer Ingelheim; Treatment for benign prostatic hypertrophy (BPH), Approved October 1997

Flovent Rotadisk; GlaxoSmithKline; Treatment of asthma in patients four and older, Approved November 1997

Floxin otic; Daiichi Sankyo; Treatment for otitis media, Approved December 1997

Follistim (TM) (follitropin beta for injection); Organon; Treatment for infertility, Approved September 1997

Fortovase; Roche; Treatment for HIV infection, Approved November 1997

Gliadel Wafer (polifeprosan 20 with carmustine implant); Rhone-Poulenc Rorer, Guilford Pharmaceuticals; Treatment for brain cancer, Approved February 1997

Glipizide Tablets; Duramed Pharmaceuticals; Treatment for diabetes, Approved September 1997

Gonal-F (follitropin alfa for injection); Serono Laboratories; Treatment for infertility, Approved September 1997

Imitrex (sumatriptan) injection and tablets; GlaxoSmithKline; Treatment for migraine headaches, Approved August 1997

Imitrex (sumatriptan) nasal spray; GlaxoSmithKline; Treatment for migraine, Approved November 1997

Interstim Continence Control Therapy; Medtronic; Treatment for incontinence, Approved September 1997

Klaron (sodium sulfacet amide lotion ) Lotion, 10%; Dermik Laboratories; Treatment for adult acne, Approved February 1997

Lescol (fluvastatin sodium); Novartis; Treatment for coronary atherosclerosis, Approved September 1997

Lexxel (enalapril maleate-felodipine ER); Astra Merck; Treatment for hypertension, Approved January 1997

Lupron Depot (leuprolide acetate for depot suspension); TAP Pharmaceuticals; Treatment for prostate cancer, Approved July 1997

LUVOX (fluvoxamine maleate); Solvay Pharmaceuticals, Pharmacia & Upjohn; Treatment for obsessive compulsive disorder (OCD) in children and adolescents, Approved April 1997

Mentax (1% butenafine HCl cream); Penederm; Treatment for athlete's foot, Approved December 1997

Metaprotereol Sulfate Inhalation Solution, 5%; Morton Grove Pharmaceuticals; Generic equivalent of Alupentr Inhalation Solution, 5%, Approved March 1997

Microzide (hydrochlorothiazide); Watson Pharmaceuticals; Treatment for mild-to moderate hypertension, Approved January 1997

Migranal; Novartis; Treatment for migraine headaches, Approved December 1997

Minoxidil Topical Solution 2% for Women; Alpharma; Generic equivalent of Rogaine, Approved April 1997

Mirapex; Pharmacia & Upjohn, Boehringer Ingelheim; Treatment for Parkinson’s Disease, Approved June 1997

NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg); Watson Pharmaceuticals; Treatment for moderate to moderately severe pain, Approved February 1997

Norvir (ritonavir); Abbott Laboratories; Treatment for HIV infection, Approved March 1996/March 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Ortho-McNeil Pharmaceutical; Treatment for acne in women seeking contraception, Approved January 1997

Pindolol; Teva Pharmaceutical; Generic equivalent of Visken, Approved April 1997

Plavix (clopidogrel bisulfate); Sanofi-aventis, Bristol-Myers Squibb; Treatment for cardiac atherosclerotic events, Approved November 1997

Posicor; Roche; Treatment for hypertension and chronic stable angina pectoris, Approved June 1997

Pramipexole; Pharmacia & Upjohn; Treatment for Parkinson's Disease, Approved July 1997

Prandin; Novo Nordisk; Treatment for Type II diabetes, Approved December 1997

Prevpac; TAP Pharmaceuticals; Treatment for duodenal ulcers, Approved December 1997

Propecia; Merck; Treatment for male baldness, Approved December 1997

Quadramet (Samarium Sm 153 Lexidronam Injection); DuPont Merck Pharmaceutical Company; Treatment for pain associated with bone cancer, Approved March 1997

Ranitidine Capsules; Geneva Pharmaceuticals; Generic equivalent of Zantac GELdose, Approved October 1997

Ranitidine Tablets; Apotex; Generic equivalent of Zantac, Approved September 1997

Raxar (grepafloxacin); GlaxoSmithKline; Treatment for chronic bronchitis, Approved November 1997

REGRANEX (becaplermin) Gel; RW Johnson; Treatment for diabetic foot ulcers, Approved December 1997

REPRONEX(menotropins for injection, USP); Ferring Pharmaceuticals; Generic equivalent of Pergonal, Approved February 1997

Requip (ropinirole hydrochloride); SmithKline Beecham; Treatment for Parkinson's Disease, Approved September 1997

Rescriptor Tablets (delavirdine mesylate tablets); Pharmacia & Upjohn; Treatment for HIV-1 infection, Approved April 1997

Retin-A Micro (tretinoin gel) microsphere, 0.1%; Advanced Polymer Systems; Treatment for acne, Approved February 1997

Selegiline tablets; Teva Pharmaceutical; Generic equivalent of Eldepryl tablets, Approved January 1997

Serevent; GlaxoSmithKline; Treatment of asthma, Approved September 1997

SPORANOX (itraconazole); Janssen Pharmaceuticals; Treatment for oral thrush, Approved March 1997

Synvisc, Synvisc-One (Hylan GF 20); Genzyme; For the treatment of pain associated with osteoarthritis of the knee, Approved August 1997

Tazorac topical gel; Allergan; Treatment for Psoriasis, Acne Vulgaris, Approved June 1997

Teveten (eprosartan mesylate); SmithKline Beecham; Treatment for hypertension, Approved December 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for mild to moderate asthma, Approved November 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for mild-to-moderate bronchial asthma, Approved April 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for asthma, Approved April 1997

Tolmetin Sodium; Teva Pharmaceutical; Treatment for arthritis, Approved March 1997

Topamax (topiramate); Ortho-McNeil Pharmaceutical; Treatment for partial onset seizures, Approved January 1997

Trazadone 150mg; Teva Pharmaceutical; Generic equivalent of Desyrel 7, Approved May 1997

Trovan; Pfizer; Treatment for bacterial infections, Approved December 1997

Vanceril 84 mcg Double Strength (beclomethasone dipropionate, 84 mcg) Inhalation Aerosol; Schering-Plough; Treatment for asthma, Approved January 1997

Verapamil; IVAX; Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR, Approved December 1997

VIRACEPT (nelfinavir mesylate); Agouron Pharmaceuticals; Treatment for HIV infection in adults and children, Approved March 1997

Zagam (sparfloxacin) tablets; Rhone Poulenc Rorer; Treatment for community-acquired pneumonia (CAP) and chronic bronchitis, Approved January 1997

Zerit (stavudine); Bristol-Myers Squibb; Treatment for infants and children infected with HIV, Approved January 1997

Zoloft (sertraline HCl); Pfizer; Treatment for panic disorder, Approved July 1997

Zoloft (sertraline HCl); Pfizer; Treatment of panic disorder in children ages 6-17, Approved October 1997

Zomig (zolmitriptan); AstraZeneca; Treatment for migraine, Approved November 1997

Zyflo (Zileuton); Abbott Laboratories; Treatment for asthma in patients 12 years and older, Approved January 1997

Gastroenterology

Asacol (mesalamine); Procter & Gamble; Treatment of ulcerative colitis, Approved August 1997

Cimetadine Hydrochloride Oral Solution 300mg/5ml; Morton Grove Pharmaceuticals; Generic equivalent of Tagamet Oral Solution, Approved October 1997

Cimetidine Hydrochloride Oral Solution; Hi-Tech Pharmacal; Generic equivalent of Tagamet Oral Solution, 300 mg/5 ml, Approved October 1997

Prevpac; TAP Pharmaceuticals; Treatment for duodenal ulcers, Approved December 1997

Prochloroperazine; Duramed Pharmaceuticals; Generic equivalent of Compazine, Approved May 1997

Ranitidine Capsules; Geneva Pharmaceuticals; Generic equivalent of Zantac GELdose, Approved October 1997

Ranitidine Tablets; Apotex; Generic equivalent of Zantac, Approved September 1997

Urso; Axcan; Treatment for primary biliary cirrhosis, Approved December 1997

Genetic Disease

BeneFIX (coagulation Factor IX (recombinant)); Genetics Institute; Treatment for hemophilia B, Approved February 1997

Carbatrol; Elan Pharmaceuticals; Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997

Galzin (zinc acetate); Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997

Tobi; PathoGenesis; Treatment for cystic fibrosis, Approved December 1997

Topamax (topiramate); Ortho-McNeil Pharmaceutical; Treatment for partial onset seizures, Approved January 1997

Hematology

Agrylin (anagrelide HCL); Roberts Pharmaceutical; Treatment for thrombocythemia, Approved March 1997

BeneFIX (coagulation Factor IX (recombinant)); Genetics Institute; Treatment for hemophilia B, Approved February 1997

Glyburide Tablets; Mova Pharmaceutical; Generic version of Glynase PresTab, Approved December 1997

Glyburide Tablets; Roche; Treatment for blood-glucose lowering, Approved December 1997

Lovenox (enoxaparin sodium) Injection; Rhone Poulenc Rorer; Treatment for deep vein thrombosis, Approved May 1997

Neumega; Genetics Institute; Treatment for thrombocytopenia, Approved November 1997

Rituxan; Biogen IDEC, Genentech; Treatment for non-hodgkin's lymphoma, Approved November 1997

Hepatology (Liver, Pancreatic, Gall Bladder)

Cimetadine Hydrochloride Oral Solution 300mg/5ml; Morton Grove Pharmaceuticals; Generic equivalent of Tagamet Oral Solution, Approved October 1997

Galzin (zinc acetate); Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997

INFERGEN (interferon alfacon-1); Amgen; Treatment for chronic hepatitis C virus, Approved October 1997

Intron A (interferon alfa-2b, recombinant); Schering-Plough; Treatment for hepatitis C, Approved March 1997

Tobi; PathoGenesis; Treatment for cystic fibrosis, Approved December 1997

Immunology

INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed); SmithKline Beecham; Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children, January 1997

Acyclovir Capsules; Teva Pharmaceutical; Generic equivalent of Zovirax, Approved April 1997

Aldara (imiquimod); 3M Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Aphthasol; Block Drug Company; Treatment for canker sores, Approved December 1997

Combivir; GlaxoSmithKline; Treatment for AIDS and HIV Infection, Approved September 1997

Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Famvir (famciclovir); SmithKline Beecham; Treatment for genital herpes, Approved September 17, 1997

Flagyl ER; Searle; Treatment for bacterial vaginosis, Approved December 1997

Flonase Nasal Spray; GlaxoSmithKline; Treatment for seasonal and perennial allergic rhinitis, Approved November 1997

Fortovase; Roche; Treatment for HIV infection, Approved November 1997

INFERGEN (interferon alfacon-1); Amgen; Treatment for chronic hepatitis C virus, Approved October 1997

Intron A (interferon alfa-2b, recombinant); Schering-Plough; Treatment for hepatitis C, Approved March 1997

Norvir (ritonavir); Abbott Laboratories; Treatment for HIV infection, Approved March 1996/March 1997

Rescriptor Tablets (delavirdine mesylate tablets); Pharmacia & Upjohn; Treatment for HIV-1 infection, Approved April 1997

SPORANOX (itraconazole); Janssen Pharmaceuticals; Treatment for oral thrush, Approved March 1997

Stromectol (ivermectin); Merck; Treatment for nondisseminated intestinal threadworm, Approved March 1997

Taxol; Bristol-Myers Squibb; Treatment for AIDS-related Kaposi's Sarcoma, Approved August 1997

Trovan; Pfizer; Treatment for bacterial infections, Approved December 1997

VIRACEPT (nelfinavir mesylate); Agouron Pharmaceuticals; Treatment for HIV infection in adults and children, Approved March 1997

Zerit (stavudine); Bristol-Myers Squibb; Treatment for infants and children infected with HIV, Approved January 1997

Infections and Infectious Diseases

Aldara (imiquimod); 3M Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Bactroban Cream; SmithKline Beecham; Treatment for secondarily infected traumatic skin lesions, Approved December 1997

Ceftin (cefuroxime axetil); GlaxoSmithKline; Treatment of secondary bacterial infections of acute bronchitis, Approved September 1997

Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet); Schering-Plough; Treatment for seasonal allergy symptoms, Approved January 1997

Combivir; GlaxoSmithKline; Treatment for AIDS and HIV Infection, Approved September 1997

Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Famvir (famciclovir); SmithKline Beecham; Treatment for genital herpes, Approved September 17, 1997

Flonase Nasal Spray; GlaxoSmithKline; Treatment for seasonal and perennial allergic rhinitis, Approved November 1997

Floxin otic; Daiichi Sankyo; Treatment for otitis media, Approved December 1997

Fortovase; Roche; Treatment for HIV infection, Approved November 1997

INFERGEN (interferon alfacon-1); Amgen; Treatment for chronic hepatitis C virus, Approved October 1997

Intron A (interferon alfa-2b, recombinant); Schering-Plough; Treatment for hepatitis C, Approved March 1997

Mentax (1% butenafine HCl cream); Penederm; Treatment for tinea corporis (ringworm) and tinea cruris (groin fungus), Approved January 1997

Mentax (1% butenafine HCl cream); Penederm; Treatment for athlete's foot, Approved December 1997

Norvir (ritonavir); Abbott Laboratories; Treatment for HIV infection, Approved March 1996/March 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Rescriptor Tablets (delavirdine mesylate tablets); Pharmacia & Upjohn; Treatment for HIV-1 infection, Approved April 1997

Taxol; Bristol-Myers Squibb; Treatment for AIDS-related Kaposi's Sarcoma, Approved August 1997

Timentin; SmithKline Beecham; Treatment for septicemia, Approved December 1997

Trovan; Pfizer; Treatment for bacterial infections, Approved December 1997

VIRACEPT (nelfinavir mesylate); Agouron Pharmaceuticals; Treatment for HIV infection in adults and children, Approved March 1997

Zerit (stavudine); Bristol-Myers Squibb; Treatment for infants and children infected with HIV, Approved January 1997

Musculoskeletal

Arthrotec; Searle; Treatment for arthritis, Approved December 1997

Atracurium Besylate Injection; Faulding; Generic equivalent of Tracrium, Approved April 1997

Estradiol tablets; Barr Laboratories; Generic equivalent of Estrace, Approved October 1997

Etodolac; Royce Laboratories; Generic equivalent of Lodine, Approved December 1997

Evista (raloxifene hydrochloride); Eli Lilly; Treatment for the prevention of osteoporosis, Approved December 1997

Ketoprofen; Schein Pharmaceutical; Generic equivalent or Oruvail, Approved December 1997

Skelid (tiludronate disodium); Sanofi-aventis; Treatment for Paget’s disease of bone, Approved March 1997

Synvisc, Synvisc-One (Hylan GF 20); Genzyme; For the treatment of pain associated with osteoarthritis of the knee, Approved August 1997

Tolmetin Sodium; Teva Pharmaceutical; Treatment for arthritis, Approved March 1997

Nephrology

EDEX; Schwarz Pharma; Treatment for erectile dysfunction, Approved June 1997

FLOMAX; Boehringer Ingelheim; Treatment for benign prostatic hypertrophy (BPH), Approved October 1997

Interstim Continence Control Therapy; Medtronic; Treatment for incontinence, Approved September 1997

Prograf; Fujisawa Healthcare; Treatment for the prevention of kidney transplant rejection, Approved April 1997

Zenapax; Roche; Treatment to prevent rejection of kidney transplants, Approved December 1997

Neurology

Bromfenac; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997

Carbatrol; Elan Pharmaceuticals; Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997

Copaxone; Teva Pharmaceutical; Treatment for relapsing-remitting multiple sclerosis, Approved January 1997

Galzin (zinc acetate); Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997

Imitrex (sumatriptan) injection and tablets; GlaxoSmithKline; Treatment for migraine headaches, Approved August 1997

Imitrex (sumatriptan) nasal spray; GlaxoSmithKline; Treatment for migraine, Approved November 1997

Migranal; Novartis; Treatment for migraine headaches, Approved December 1997

Mirapex; Pharmacia & Upjohn, Boehringer Ingelheim; Treatment for Parkinson’s Disease, Approved June 1997

NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg); Watson Pharmaceuticals; Treatment for moderate to moderately severe pain, Approved February 1997

Oxycodone with Acetaminophen 5mg/325mg; Watson Pharmaceuticals; Generic equivalent of Percocet and Tylox, Approved November 1997

Pramipexole; Pharmacia & Upjohn; Treatment for Parkinson's Disease, Approved July 1997

Quadramet (Samarium Sm 153 Lexidronam Injection); DuPont Merck Pharmaceutical Company; Treatment for pain associated with bone cancer, Approved March 1997

Requip (ropinirole hydrochloride); SmithKline Beecham; Treatment for Parkinson's Disease, Approved September 1997

Selegiline tablets; Teva Pharmaceutical; Generic equivalent of Eldepryl tablets, Approved January 1997

Topamax (topiramate); Ortho-McNeil Pharmaceutical; Treatment for partial onset seizures, Approved January 1997

VERSED (midazolam HCI); Roche; Treatment for sedating children who must undergo painful surgery, Approved March 1997

Zomig (zolmitriptan); AstraZeneca; Treatment for migraine, Approved November 1997

Nutrition and Weight Loss

MERIDIA; Knoll Pharmaceutical; Treatment for obesity, Approved November 1997

Obstetrics/Gynecology (Women’s Health)

Alesse (100 mcg levonorgestrel/20 mcg ethinyl estradiol tablets); Wyeth; Treatment for the prevention of pregnancy, Approved April 1997

Crinone 8% (progesterone gel); Wyeth; Treatment for infertile women with pregestone deficiency, Approved May 1997

Estradiol tablets; Barr Laboratories; Generic equivalent of Estrace, Approved October 1997

Estradiol tablets; Duramed Pharmaceuticals; Generic equivalent of Estrace tablets, Approved December 1997

Estrostep (norethindrone acetate and ethinyl estradiol); Warner-Lambert; Treatment for oral contraception, Approved March 1997

Evista (raloxifene hydrochloride); Eli Lilly; Treatment for the prevention of osteoporosis, Approved December 1997

Femara (letrozole); Novartis; Treatment for breast cancer, Approved July 1997

FEMSTAT One; Roche; Treatment for vaginal yeast infections, Approved Februrary 1997

Flagyl ER; Searle; Treatment for bacterial vaginosis, Approved December 1997

Floxin Tablets (ofloxacin tablets); Ortho-McNeil Pharmaceutical; Treatment for pelvic inflammatory disease (PID), Approved January 1997

Follistim (TM) (follitropin beta for injection); Organon; Treatment for infertility, Approved September 1997

Gonal-F (follitropin alfa for injection); Serono Laboratories; Treatment for infertility, Approved September 1997

Miraluma test; DuPont Merck Pharmaceutical Company; Test for breast cancer, Approved May 1997

Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Ortho-McNeil Pharmaceutical; Treatment for acne in women seeking contraception, Approved January 1997

Trivora-21 and Trivora-28; Watson Pharmaceuticals; Generic equivalents of levonorgestrel and ethinyl estradiol, Approved December 1997

Oncology

Anzemet; Hoechst Marion Roussel; Treatment for emesis, Approved September 1997

Bromfenac; Duract, Wyeth-Ayerst Laboratories; Management of acute pain, Approved July 1997

Femara (letrozole); Novartis; Treatment for breast cancer, Approved July 1997

Gliadel Wafer (polifeprosan 20 with carmustine implant); Rhone-Poulenc Rorer, Guilford Pharmaceuticals; Treatment for brain cancer, Approved February 1997

Intron A (interferon alfa-2b, recombinant); Schering-Plough; Treatment for non-Hodgkin's lymphoma, Approved December 1997

Kytril (granisetron) tablets; SmithKline Beecham; Prevention of nausea and vomiting associated with chemotherapy, Approved November 1997

Lupron Depot (leuprolide acetate for depot suspension); TAP Pharmaceuticals; Treatment for prostate cancer, Approved July 1997

Miraluma test; DuPont Merck Pharmaceutical Company; Test for breast cancer, Approved May 1997

Neumega; Genetics Institute; Treatment for thrombocytopenia, Approved November 1997

Quadramet (Samarium Sm 153 Lexidronam Injection); DuPont Merck Pharmaceutical Company; Treatment for pain associated with bone cancer, Approved March 1997

Rituxan; Biogen IDEC, Genentech; Treatment for non-hodgkin's lymphoma, Approved November 1997

Taxol; Bristol-Myers Squibb; Treatment for AIDS-related Kaposi's Sarcoma, Approved August 1997

Ophthalmology

Acular (ketorolac tromethamine ophthalmic solution) 0.5%; Allergan; Treatment for post-surgical inflammation following cataract extraction, Approved November 1997

Acular (ketorolac tromethamine ophthalmic solution) 0.5%; Allergan; Treatment for postoperative inflammation in patients who have undergone cataract extraction, Approved January 1997

BSS Sterile Irrigating Solution; Alcon; Treatment during ocular surgical procedures, Approved December 1997

Otolaryngology (Ear, Nose, Throat)

Floxin otic; Daiichi Sankyo; Treatment for otitis media, Approved December 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Pediatrics/Neonatology

INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed); SmithKline Beecham; Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children, January 1997

AneuVysion Assay; Vysis; Genetic test for birth defects, Approved October 1997

Antizol Injection; Orphan Medical; Treatment for ethylene glycol poisoning, Approved December 1997

Flovent Rotadisk; GlaxoSmithKline; Treatment of asthma in patients four and older, Approved November 1997

Floxin otic; Daiichi Sankyo; Treatment for otitis media, Approved December 1997

Geref (sermorelin acetate for injection); Serono Laboratories; Treatment for pedicatric growth disorder, Approved October 1997

Norditropin (somatropin (rDNA origin) for injection); Novo Nordisk; Treatment of children who have growth failure, Approved February 1997

Norvir (ritonavir); Abbott Laboratories; Treatment for HIV infection, Approved March 1996/March 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for asthma, Approved April 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for mild-to-moderate bronchial asthma, Approved April 1997

Timentin; SmithKline Beecham; Treatment for septicemia, Approved December 1997

Tobi; PathoGenesis; Treatment for cystic fibrosis, Approved December 1997

VERSED (midazolam HCI); Roche; Treatment for sedating children who must undergo painful surgery, Approved March 1997

VIRACEPT (nelfinavir mesylate); Agouron Pharmaceuticals; Treatment for HIV infection in adults and children, Approved March 1997

Zerit (stavudine); Bristol-Myers Squibb; Treatment for infants and children infected with HIV, Approved January 1997

Zoloft (sertraline HCl); Pfizer; Treatment of panic disorder in children ages 6-17, Approved October 1997

Pharmacology/Toxicology

AneuVysion Assay; Vysis; Genetic test for birth defects, Approved October 1997

Antizol Injection; Orphan Medical; Treatment for ethylene glycol poisoning, Approved December 1997

Galzin (zinc acetate); Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997

Kytril (granisetron) tablets; SmithKline Beecham; Prevention of nausea and vomiting associated with chemotherapy, Approved November 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Oxycodone with Acetaminophen 5mg/325mg; Watson Pharmaceuticals; Generic equivalent of Percocet and Tylox, Approved November 1997

Trovan; Pfizer; Treatment for bacterial infections, Approved December 1997

Podiatry

Aldara (imiquimod); 3M Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals; Treatment for external genital and perianal warts, Approved March 1997

Mentax (1% butenafine HCl cream); Penederm; Treatment for athlete's foot, Approved December 1997

REGRANEX (becaplermin) Gel; RW Johnson; Treatment for diabetic foot ulcers, Approved December 1997

Psychiatry/Psychology

Effexor XR (venlafaxin HCI); Wyeth; Treatment of depression, Approved October 1997

Generic Transdermal Nicotine Patch; Sano; Generic equivalent of Habitrol, Approved October 1997

LUVOX (fluvoxamine maleate); Solvay Pharmaceuticals, Pharmacia & Upjohn; Treatment for obsessive compulsive disorder (OCD) in children and adolescents, Approved April 1997

Seroquel (R) (quetiapine fumarate) Tablets; AstraZeneca; Treatment for schizophrenia, Approved September 1997

Trazadone 150mg; Teva Pharmaceutical; Generic equivalent of Desyrel 7, Approved May 1997

Zoloft (sertraline HCl); Pfizer; Treatment for panic disorder, Approved July 1997

Zoloft (sertraline HCl); Pfizer; Treatment of panic disorder in children ages 6-17, Approved October 1997

Zyban Sustained-Release Tablets; GlaxoSmithKline; Treatment for smoking cessation, Approved May 1997

Pulmonary/Respiratory Diseases

Ceftin (cefuroxime axetil); GlaxoSmithKline; Treatment of secondary bacterial infections of acute bronchitis, Approved September 1997

Cipro (ciprofloxacin HCl); Bayer; Treatment for acute sinusitis, Approved June 1997

Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet); Schering-Plough; Treatment for seasonal allergy symptoms, Approved January 1997

Flonase Nasal Spray; GlaxoSmithKline; Treatment for seasonal and perennial allergic rhinitis, Approved November 1997

Flovent Rotadisk; GlaxoSmithKline; Treatment of asthma in patients four and older, Approved November 1997

Metaprotereol Sulfate Inhalation Solution, 5%; Morton Grove Pharmaceuticals; Generic equivalent of Alupentr Inhalation Solution, 5%, Approved March 1997

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Raxar (grepafloxacin); GlaxoSmithKline; Treatment for chronic bronchitis, Approved November 1997

Serevent; GlaxoSmithKline; Treatment of asthma, Approved September 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for mild to moderate asthma, Approved November 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for asthma, Approved April 1997

Tilade (nedocromil sodium); Rhone Poulenc Rorer; Treatment for mild-to-moderate bronchial asthma, Approved April 1997

Tobi; PathoGenesis; Treatment for cystic fibrosis, Approved December 1997

Vanceril 84 mcg Double Strength (beclomethasone dipropionate, 84 mcg) Inhalation Aerosol; Schering-Plough; Treatment for asthma, Approved January 1997

Zagam (sparfloxacin) tablets; Rhone Poulenc Rorer; Treatment for community-acquired pneumonia (CAP) and chronic bronchitis, Approved January 1997

Zyflo (Zileuton); Abbott Laboratories; Treatment for asthma in patients 12 years and older, Approved January 1997

Rheumatology

Arthrotec; Searle; Treatment for arthritis, Approved December 1997

Etodolac; Royce Laboratories; Generic equivalent of Lodine, Approved December 1997

Etodolac; Royce Laboratories; Generic equivalent of Lodine, Approved April 1997

Ketoprofen; Schein Pharmaceutical; Generic equivalent or Oruvail, Approved December 1997

Synvisc, Synvisc-One (Hylan GF 20); Genzyme; For the treatment of pain associated with osteoarthritis of the knee, Approved August 1997

Tolmetin Sodium; Teva Pharmaceutical; Treatment for arthritis, Approved March 1997

Urology

INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed); SmithKline Beecham; Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children, January 1997

EDEX; Schwarz Pharma; Treatment for erectile dysfunction, Approved June 1997

FEMSTAT One; Roche; Treatment for vaginal yeast infections, Approved Februrary 1997

FLOMAX; Boehringer Ingelheim; Treatment for benign prostatic hypertrophy (BPH), Approved October 1997

Follistim (TM) (follitropin beta for injection); Organon; Treatment for infertility, Approved September 1997

Gonal-F (follitropin alfa for injection); Serono Laboratories; Treatment for infertility, Approved September 1997

Interstim Continence Control Therapy; Medtronic; Treatment for incontinence, Approved September 1997

Lupron Depot (leuprolide acetate for depot suspension); TAP Pharmaceuticals; Treatment for prostate cancer, Approved July 1997

REPRONEX(menotropins for injection, USP); Ferring Pharmaceuticals; Generic equivalent of Pergonal, Approved February 1997

SPORANOX (itraconazole); Janssen Pharmaceuticals; Treatment for oral thrush, Approved March 1997

Vaccines

Omnicef; Warner-Lambert; Treatment against various bacterias, Approved December 1997

Trovan; Pfizer; Treatment for bacterial infections, Approved December 1997

Zagam (sparfloxacin) tablets; Rhone Poulenc Rorer; Treatment for community-acquired pneumonia (CAP) and chronic bronchitis, Approved January 1997